FzM1
CAS: 1680196-54-6
Ref. 3D-FSC19654
5mg | Descatalogado | ||
10mg | Descatalogado | ||
25mg | Descatalogado | ||
50mg | Descatalogado | ||
100mg | Descatalogado |
Información del producto
FzM1 is a translation inhibitor that binds to the ribosomal protein S6 (RPS6) and inhibits the translation of human lung cancer cells. FzM1 binds to RPS6, which is a protein target for cancer therapy. This binding prevents the formation of an active complex between RPS6 and chaperones, leading to a decrease in protein synthesis and cell growth. FzM1 has been shown to have anti-cancer properties by inhibiting the development of cancer stem cells. FzM1 also has allosteric modulator activity, which may be due to its ability to inhibit protein localization or positioning.